Mutant Huntingtin Does Not Affect the Intrinsic Phenotype of Human Huntington's Disease T Lymphocytes

被引:11
|
作者
Miller, James R. C. [1 ]
Traeger, Ulrike [1 ]
Andre, Ralph [1 ]
Tabrizi, Sarah J. [1 ]
机构
[1] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England
来源
PLOS ONE | 2015年 / 10卷 / 11期
基金
英国医学研究理事会;
关键词
NF-KAPPA-B; IN-VIVO; PROLIFERATION; ACTIVATION; DIFFERENTIATION; TRANSCRIPTION; PATHWAY; ONSET;
D O I
10.1371/journal.pone.0141793
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Huntington's disease is a fatal neurodegenerative condition caused by a CAG repeat expansion in the huntingtin gene. The peripheral innate immune system is dysregulated in Huntington's disease and may contribute to its pathogenesis. However, it is not clear whether or to what extent the adaptive immune system is also involved. Here, we carry out the first comprehensive investigation of human ex vivo T lymphocytes in Huntington's disease, focusing on the frequency of a range of T lymphocyte subsets, as well as analysis of proliferation, cytokine production and gene transcription. In contrast to the innate immune system, the intrinsic phenotype of T lymphocytes does not appear to be affected by the presence of mutant huntingtin, with Huntington's disease T lymphocytes exhibiting no significant functional differences compared to control cells. The transcriptional profile of T lymphocytes also does not appear to be significantly affected, suggesting that peripheral immune dysfunction in Huntington's disease is likely to be mediated primarily by the innate rather than the adaptive immune system. This study increases our understanding of the effects of Huntington's disease on peripheral tissues, while further demonstrating the differential effects of the mutant protein on different but related cell types. Finally, this study suggests that the potential use of novel therapeutics aimed at modulating the Huntington's disease innate immune system should not be extended to include the adaptive immune system.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Genistein induces degradation of mutant huntingtin in fibroblasts from Huntington's disease patients
    Pierzynowska, Karolina
    Gaffke, Lidia
    Cyske, Zuzanna
    Wegrzyn, Grzegorz
    METABOLIC BRAIN DISEASE, 2019, 34 (03) : 715 - 720
  • [42] Genetic manipulations of mutant huntingtin in mice: new insights into Huntington's disease pathogenesis
    Lee, C. Y. Daniel
    Cantle, Jeffrey P.
    Yang, X. William
    FEBS JOURNAL, 2013, 280 (18) : 4382 - 4394
  • [43] Copper enhances aggregational toxicity of mutant huntingtin in a Drosophila model of Huntington's Disease
    Lobato, Amanda G.
    Ortiz-Vega, Natalie
    Zhu, Yi
    Neupane, Deepa
    Meier, Katlyn K.
    Zhai, R. Grace
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2024, 1870 (01):
  • [44] Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients
    Wild, Edward J.
    Boggio, Roberto
    Langbehn, Douglas
    Robertson, Nicola
    Haider, Salman
    Miller, James R. C.
    Zetterberg, Henrik
    Leavitt, Blair R.
    Kuhn, Rainer
    Tabrizi, Sarah J.
    Macdonald, Douglas
    Weiss, Andreas
    JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (05): : 1979 - 1986
  • [45] Lowering mutant huntingtin by small molecules relieves Huntington's disease symptoms and progression
    Bahat, Anat
    Itzhaki, Elad
    Weiss, Benjamin
    Tolmasov, Michael
    Tsoory, Michael
    Kuperman, Yael
    Brandis, Alexander
    Shurrush, Khriesto A.
    Dikstein, Rivka
    EMBO MOLECULAR MEDICINE, 2024, 16 (03) : 523 - 546
  • [46] Mutant Huntingtin is Present in Neuronal Grafts in Huntington Disease Patients
    Cicchetti, Francesca
    Lacroix, Steve
    Cisbani, Giulia
    Vallieres, Nicolas
    Saint-Pierre, Martine
    St-Amour, Isabelle
    Tolouei, Ranna
    Skepper, Jeremy N.
    Hauser, Robert A.
    Mantovani, Diego
    Barker, Roger A.
    Freeman, Thomas B.
    ANNALS OF NEUROLOGY, 2014, 76 (01) : 31 - 42
  • [47] Pleiotropic effects of mutant huntingtin on retinopathy in two mouse models of Huntington's disease
    Xu, Hui
    Ajayan, Anakha
    Langen, Ralf
    Chen, Jeannie
    NEUROBIOLOGY OF DISEASE, 2025, 205
  • [48] Mutant Huntingtin-Calmodulin Interaction: Potential Therapeutic Target for Huntington's Disease
    Kapadia, Khushboo
    Roy, Anuradha
    McDonald, Peter
    Klus, Nicholas
    Frankowski, Kevin
    Aube, Jeffrey
    Muma, Nancy
    FASEB JOURNAL, 2019, 33
  • [49] The pathobiology of perturbed mutant huntingtin protein-protein interactions in Huntington's disease
    Wanker, Erich E.
    Ast, Anne
    Schindler, Franziska
    Trepte, Philipp
    Schnoegl, Sigrid
    JOURNAL OF NEUROCHEMISTRY, 2019, 151 (04) : 507 - 519
  • [50] Mutant huntingtin expression in microglia is neither required nor sufficient to cause the Huntington's disease-like phenotype in BACHD mice
    Petkau, Terri L.
    Hill, Austin
    Connolly, Colum
    Lu, Ge
    Wagner, Pam
    Kosior, Natalia
    Blanco, Jake
    Leavitt, Blair R.
    HUMAN MOLECULAR GENETICS, 2019, 28 (10) : 1661 - 1670